Search

everythinglearnresearchcommunity

for

Search:↓

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

WNT10B is linked to cancer development and affects survival and disease progression in various cancers.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

CT scans can find serious prostate cancer even when PSA levels are low.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

TGF-β is crucial for tissue repair and can cause diseases if not properly regulated.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

TMPRSS2 helps viruses enter cells and protects the prostate from inflammation-related cancer.

Low Vitamin D receptor levels in breast cancer are linked to worse outcomes and more bone metastases, and could be a marker for prognosis.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

ERG increases SOX9, promoting prostate cancer growth and invasion.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Nitric Oxide has potential in medicine, especially for infections and heart treatments, but its short life and delivery challenges limit its use.

CXXC5 is a protein that controls cell growth and healing processes, and changes in its activity can lead to diseases like cancer and hair loss.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.